In conclusion, this study demonstrates that SRC‐1 promotes HCC metastasis via enhancing MMP‐9 expression, indicating that inhibition of SRC‐1 may be an efficient therapeutic strategy for controlling HCC metastasis. Here, SRC is linked to hepatocellular carcinoma.